Irene Perlich

Insider Reports History

Entity
Individual
Location
C/O Ngm Biopharmaceuticals, Inc., 333 Oyster Point Boulevard, South San Francisco, CA
Signature
/s/ Valerie Pierce, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Irene Perlich:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NGM BIOPHARMACEUTICALS INC Principal Accounting Officer Common Stock 0 $0 $1.34 Apr 5, 2024 Direct
NGM BIOPHARMACEUTICALS INC Principal Accounting Officer Restricted Stock Unit 0 $0 $1.34 Apr 5, 2024 Direct
NGM BIOPHARMACEUTICALS INC Principal Accounting Officer Stock Option (Right to Buy) 0 Apr 5, 2024 Direct

Insider Reports Filed by Irene Perlich

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NGM NGM BIOPHARMACEUTICALS INC Apr 5, 2024 7 $0 4 Apr 8, 2024 Principal Accounting Officer
NGM NGM BIOPHARMACEUTICALS INC Jan 16, 2024 1 -$1.37K 4 Jan 18, 2024 PRINCIPAL ACCOUNTING OFFICER
NGM NGM BIOPHARMACEUTICALS INC Nov 6, 2023 6 $0 4 Nov 8, 2023 Principal Accounting Officer
NGM NGM BIOPHARMACEUTICALS INC Sep 15, 2023 0 $0 3 Sep 18, 2023 Principal Accounting Officer